{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "PARK7 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 are associated with autosomal-recessive early-onset Parkinson's disease (PD). DJ-1 acts as a redox-dependent chaperone and regulator of transcription. The study links DJ-1 dysfunction to apoptosis via TTRAP interaction and JNK/p38-MAPK pathways.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism, linking PARK7 mutations to PD through disrupted redox regulation, TTRAP interaction, and apoptosis pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of the assay",
          "extracted_paper_info": "Yeast two-hybrid screening and cell apoptosis assays were used to study TTRAP binding and DJ-1 mutant effects. These assays directly test PD-relevant mechanisms (apoptosis, protein interaction).",
          "judgment": "Yes",
          "reasoning": "The assays (protein interaction and cell death) are directly relevant to PD pathogenesis, validating their applicability."
        },
        {
          "step_name": "Step 3a: Basic controls",
          "extracted_paper_info": "Wild-type DJ-1 was used as a control for mutant (M26I) comparisons. TTRAP's protective role was tested against mutant DJ-1.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type DJ-1 and TTRAP experiments) were explicitly referenced in the study."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "No known pathogenic or benign variants were used as controls; only M26I and L166P mutants were tested.",
          "judgment": "No",
          "reasoning": "The study did not include external variant controls (e.g., known pathogenic/benign variants) for comparison."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Only two variants (M26I and L166P) were tested. No statistical oddsPath values were reported.",
          "judgment": "Yes",
          "reasoning": "The study tested fewer than 10 variant controls, limiting statistical rigor."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "PARK7 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 are associated with autosomal-recessive early-onset PD. The study highlights DJ-1's role in redox regulation and TTRAP-mediated apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism, linking PARK7 mutations to PD through disrupted redox regulation and apoptosis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of the assay",
          "extracted_paper_info": "Yeast two-hybrid screening and cell apoptosis assays were used to study TTRAP binding and DJ-1 mutant effects. These assays directly test PD-relevant mechanisms (apoptosis, protein interaction).",
          "judgment": "Yes",
          "reasoning": "The assays (protein interaction and cell death) are directly relevant to PD pathogenesis, validating their applicability."
        },
        {
          "step_name": "Step 3a: Basic controls",
          "extracted_paper_info": "Wild-type DJ-1 was used as a control for mutant (L166P) comparisons. TTRAP's protective role was tested against mutant DJ-1.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type DJ-1 and TTRAP experiments) were explicitly referenced in the study."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "No known pathogenic or benign variants were used as controls; only M26I and L166P mutants were tested.",
          "judgment": "No",
          "reasoning": "The study did not include external variant controls (e.g., known pathogenic/benign variants) for comparison."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Only two variants (M26I and L166P) were tested. No statistical oddsPath values were reported.",
          "judgment": "Yes",
          "reasoning": "The study tested fewer than 10 variant controls, limiting statistical rigor."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    }
  ]
}